Suheung Co., Ltd. (KRX:008490)
18,350
-510 (-2.70%)
Jun 4, 2026, 12:34 PM KST
Suheung Revenue
Suheung had revenue of 201.55B KRW in the quarter ending March 31, 2026, with 11.45% growth. This brings the company's revenue in the last twelve months to 743.02B, up 11.10% year-over-year. In the year 2025, Suheung had annual revenue of 722.31B with 10.57% growth.
Revenue (ttm)
743.02B
Revenue Growth
+11.10%
P/S Ratio
0.28
Revenue / Employee
1.01B
Employees
738
Market Cap
210.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 722.31B | 69.04B | 10.57% |
| Dec 31, 2024 | 653.26B | 58.70B | 9.87% |
| Dec 31, 2023 | 594.57B | -40.40B | -6.36% |
| Dec 31, 2022 | 634.97B | 38.23B | 6.41% |
| Dec 31, 2021 | 596.73B | 43.72B | 7.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chong Kun Dang Holdings | 952.66B |
| Daewon Pharmaceutical | 605.66B |
| Samjin Pharmaceuticals | 274.03B |
| Whan In Pharm | 266.19B |
| JW Lifescience | 252.72B |
| Boditech Med | 165.84B |
| Yungjin Pharm. | 158.79B |
| REYON Pharmaceutical | 145.22B |